Garda Therapeutics

About Garda Therapeutics

Garda Therapeutics is an emerging pharmaceutical company focused on maximizing returns from mid-sized specialty assets through strategic acquisitions and attractive licensing opportunities. The company emphasizes building customized infrastructures and leveraging a highly experienced management team with a track record in acquiring and licensing assets, as well as optimizing asset growth in sophisticated specialty markets. Garda targets oncology assets, including hematology and solid tumors, and pursues clinical development for new indications and label expansions to create stakeholder value. Services are managed with internal staff or via experienced external partners to tailor solutions for diverse asset opportunities.